Nahdi Medical Company
4164
株式のランク
#4859
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
株価
$23.36
時価総額
$3.04B
変化（1日）
-0.28%
変化（1年）
-26.94%
国
SA
取引 Nahdi Medical Company (4164)
カテゴリー
Healthcare
Nahdi Medical Company（4164）の収益
Jun 2026 時点の収益 TTM: $2.80B
Nahdi Medical Company の最新の財務報告によると、現在の収益 (TTM) は $2.80B です。2023 年には $2.32B の収益があり、これは 2022 年の $2.29B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Nahdi Medical Company の収益履歴（2017 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $2.80B | 11.55% |
| 2024 | $2.51B | 8.21% |
| 2023 | $2.32B | 1.37% |
| 2022 | $2.29B | 6.69% |
| 2021 | $2.15B | -6.73% |
| 2020 | $2.30B | 10.44% |
| 2019 | $2.09B | 6.47% |
| 2018 | $1.96B | 4.11% |
| 2017 | $1.88B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $2.54B | -9.59% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $830.81M | -70.38% |
US
|
